Literature DB >> 11750036

The machinery of programmed cell death.

K C Zimmermann1, C Bonzon, D R Green.   

Abstract

Apoptosis or programmed cell death is an essential physiological process that plays a critical role in development and tissue homeostasis. However, apoptosis is also involved in a wide range of pathological conditions. Apoptotic cells may be characterized by specific morphological and biochemical changes, including cell shrinkage, chromatin condensation, and internucleosomal cleavage of genomic DNA. At the molecular level, apoptosis is tightly regulated and is mainly orchestrated by the activation of the aspartate-specific cysteine protease (caspase) cascade. There are two main pathways leading to the activation of caspases. The first of these depends upon the participation of mitochondria (receptor-independent) and the second involves the interaction of a death receptor with its ligand. Pro- and anti-apoptotic members of the Bcl-2 family regulate the mitochondrial pathway. Cellular stress induces pro-apoptotic Bcl-2 family members to translocate from the cytosol to the mitochondria, where they induce the release of cytochrome c, while the anti-apoptotic Bcl-2 proteins work to prevent cytochrome c release from mitochondria, and thereby preserve cell survival. Once in the cytoplasm, cytochrome c catalyzes the oligomerization of apoptotic protease activating factor-1, thereby promoting the activation of procaspase-9, which then activates procaspase-3. Alternatively, ligation of death receptors, like the tumor necrosis factor receptor-1 and the Fas receptor, causes the activation of procaspase-8. The mature caspase may now either directly activate procaspase-3 or cleave the pro-apoptotic Bcl-2 homology 3-only protein Bid, which then subsequently induces cytochrome c release. Nevertheless, the end result of either pathway is caspase activation and the cleavage of specific cellular substrates, resulting in the morphological and biochemical changes associated with the apoptotic phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750036     DOI: 10.1016/s0163-7258(01)00159-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  170 in total

Review 1.  Do apoptotic mechanisms regulate synaptic plasticity and growth-cone motility?

Authors:  Charles P Gilman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

2.  Exponential growth by cross-catalytic cleavage of deoxyribozymogens.

Authors:  Matthew Levy; Andrew D Ellington
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

3.  Ian4 is required for mitochondrial integrity and T cell survival.

Authors:  Malini Pandarpurkar; Leanne Wilson-Fritch; Silvia Corvera; Helle Markholst; Lars Hornum; Dale L Greiner; John P Mordes; Aldo A Rossini; Rita Bortell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-20       Impact factor: 11.205

4.  Inhibition of apoptosis by Escherichia coli K1 is accompanied by increased expression of BclXL and blockade of mitochondrial cytochrome c release in macrophages.

Authors:  Sunil K Sukumaran; Suresh K Selvaraj; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  Long-term growth selection of mice changes the intrinsic susceptibility of myogenic cells to apoptosis.

Authors:  Charlotte Rehfeldt; Ulla Renne; Matthias Wittstock; Eilhard Mix; Uwe K Zettl
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

Review 6.  Apoptotic signaling in mouse odontogenesis.

Authors:  Eva Matalova; Eva Svandova; Abigail S Tucker
Journal:  OMICS       Date:  2011-12-28

7.  Protective effect of Bu-7, a flavonoid extracted from Clausena lansium, against rotenone injury in PC12 cells.

Authors:  Bo-yu Li; Yu-he Yuan; Jin-feng Hu; Qing Zhao; Dong-ming Zhang; Nai-hong Chen
Journal:  Acta Pharmacol Sin       Date:  2011-10-03       Impact factor: 6.150

8.  IRP2 regulates breast tumor growth.

Authors:  Wei Wang; Zhiyong Deng; Heather Hatcher; Lance D Miller; Xiumin Di; Lia Tesfay; Guangchao Sui; Ralph B D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Cancer Res       Date:  2013-11-27       Impact factor: 12.701

9.  Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

Authors:  Tai-Guang Jin; Alexei Kurakin; Nordine Benhaga; Karon Abe; Mehrdad Mohseni; Ferry Sandra; Keli Song; Brian K Kay; Roya Khosravi-Far
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

10.  The role of Bcl-2 family members in the progression of cutaneous melanoma.

Authors:  Jason A Bush; Gang Li
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.